Tibsovo (Ivosidenib)
- Medicine Name: Tibsovo
- Generic Name: Ivosidenib
- Dosage Form & Strength: Tablets: 250 mg
- Manufactured By: Servier Pharmaceuticals
- Newly diagnosed AML, either in combination with azacitidine or alone, for individuals aged 75 years or older, or those unable to tolerate certain chemotherapy treatments due to health issues.
- AML that has relapsed or has not responded to prior treatment(s).
- MDS that has relapsed or has not responded to previous treatment(s).
- For bile duct cancer that has metastasized and has already been treated with previous therapy.
- Differentiation Syndrome in AML
- QTc Interval Prolongation
- Storage and Handling:
What documents are required to import Trodelvy?
Trodelvy (sacituzumab govitecan-hziy) can be imported by patients or government hospitals on behalf of patients. The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patient’s diagnostic reports.
- Patient’s ID proof (issued by the Government of the respective country).
How is the order confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from a doctor.
- Import permit if applicable.
Is Trodelvy available worldwide?
Trodelvy (sacituzumab govitecan-hziy) is a prescription pharmaceutical drug that legally requires a medical prescription for dispensation.
Urgent Meds facilitates the import of critical medications like Trodelvy globally, ensuring the named patient supply (NPS). Urgent Meds is the facilitator that provides essential support for:
- Availability of Trodelvy (Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, and Sri Lanka).
- Trodelvy available in India (Noida, Delhi, Mumbai, Gurgaon, Lucknow, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, and Pune, etc.).
- Determining Medicine Price.
- Sourcing genuine and reliable sources from the USA, Canada, Europe, and Australia.
- Ensuring 100% transparency.
Trodelvy can be made available to patients, doctors, and hospitals in various countries across the globe. The order will be confirmed only after receiving a valid prescription from the doctor and, if required, an import permit.
Urgent Meds can facilitate the supply of Trodelvy (prescription medicine) to locations worldwide while adhering to legal requirements (if applicable).
For inquiries about the price of Trodelvy, please contact:
Phone: +16478184196
Email: info@indianpharmanetwork.in
We assure quality and worldwide delivery as per the buyer’s specifications.
Urgent Meds is proficient in sourcing Trodelvy (sacituzumab govitecan-hziy) from around the world and has the capability to supply it. We offer global access to the best available treatment for our customers worldwide in countries like Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, and Sri Lanka.
Urgent Meds is committed to dispensing any valid prescription promptly. All prescriptions are dispensed and verified by registered pharmacists and are dispatched only to the patient’s address. Your health and well-being are our top priorities.
What is the Generic Name for the trade name drug Tibsovo®?
Ivosidenib is the Generic Name for the trade name drug Tibsovo®.
What is the Manufacturer’s Name of Tibsovo®?
Tibsovo® is manufactured by Servier Pharmaceuticals.
Is Tibsovo® approved by the FDA?
Yes, Tibsovo® is approved by the FDA. Date of first/initial approval: July 20, 2018.
Where can I get Tibsovo® at the best price in India?
To get the best Tibsovo 250 mg tablet price in India, contact Urgent Meds (a WHO-GDP & ISO 9001:2008 authorized company). A medical prescription is required while buying Tibsovo®.
What is the dosage and form of Tibsovo® supplied?
Tibsovo® is supplied as Tablets: 250 mg for oral administration.
What are the most common side effects with Tibsovo® when used along with azacitidine or alone in adults with AML?
The most common side effects with Tibsovo® when used along with azacitidine or alone in adults with AML include changes in certain blood cell counts, diarrhea, increased blood sugar, fatigue, changes in certain liver function tests, swelling of arms or legs, decreased levels of electrolytes in the blood, nausea, vomiting, decreased appetite, joint pain, shortness of breath, uric acid increased, stomach (abdominal) pain, changes in certain kidney function tests, pain or sores in your mouth or throat, rash, irregular heart rhythm or heartbeat (QTc prolongation), differentiation syndrome, and muscle pain.
What are the most common side effects with Tibsovo® when used in patients with cholangiocarcinoma?
The most common side effects (≥15%) in patients with cholangiocarcinoma are fatigue, nausea, abdominal pain, diarrhea, cough, decreased appetite, ascites, vomiting, anemia, and rash.
How much does Tibsovo® cost in India?
Tibsovo cost in India is less and can vary. To buy/procure this IDH1 inhibitor authentically, you can Call/WhatsApp +16478184196 or send mail to info@urgentmeds.com.
What are the storage conditions of Tibsovo®?
Tibsovo® is available as 250 mg tablets. Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F).
Is it safe to buy Tibsovo® online from India?
Yes, you can buy Tibsovo tablets in India online at the best price from Urgent Meds if Tibsovo® has not been approved or is not available in your country.
What is the latest FDA approval for Tibsovo?
The FDA has recently approved Tibsovo for the treatment of relapsed or refractory myelodysplastic syndromes (MDS) with an IDH1 mutation. This approval is based on the results of a Phase I clinical trial, which demonstrated significant efficacy in this patient population.
How does Tibsovo work in treating MDS?
Tibsovo targets and inhibits the mutant IDH1 enzyme, which is involved in the abnormal proliferation of cancer cells. By inhibiting this enzyme, Tibsovo helps to reduce the growth and spread of cancer cells in patients with IDH1-mutated MDS.
Is Tibsovo available in South Asia?
Tibsovo tablets are available in Asian countries like Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, and Sri Lanka.
What are the key findings from the clinical trials of Tibsovo for MDS?
The clinical trial showed a complete remission rate of 38.9% and an objective response rate of 83.3%. The median time to complete remission was 1.9 months. These results indicate that Tibsovo is highly effective in inducing remission in patients with IDH1-mutated MDS.
Is there any specific diagnostic test required before starting Tibsovo?
Yes, the Abbott RealTime IDH1 Assay diagnostic device has been approved to help identify patients with IDH1 mutations who may benefit from Tibsovo. This test ensures that the treatment is targeted to patients most likely to respond.
Is Tibsovo available in the Maldives?
Yes, Urgent Meds can facilitate the supply of Tibsovo to the Maldives while adhering to legal requirements.
Is Tibsovo a chemotherapy drug?
Acute myeloid leukemia (AML), a form of cancer, is treated with Tibsovo. It is not, however, a chemotherapy medicine.
Where is Tibsovo available in India?
Tibsovo is available in India (Noida, Delhi, Mumbai, Gurgaon, Lucknow, Kolkata, Hyderabad, Chennai, Ahmedabad, Bangalore, and Pune, etc.).
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.